ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.636,96
1,07%
S&P 500
5.447,87
-0,31%
US Dollar vs BRL
5,3907
0,00%
Bitcoin
60.957,08
1,15%
Brent Oil
85,205
-0,08%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Statera BioPharma Inc (STAB)

  7. Statera BioPharma Inc (STAB) Notícias

STAB

Statera BioPharma (STAB)

Statera BioPharma Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:STAB
DataHoraFonteTítuloCódigoCompanhia
15/03/202309:00GlobeNewswire Inc.Statera Biopharma Signs Letter of Intent for Merger with Worksite LabsNASDAQ:STABStatera BioPharma Inc
03/03/202312:47Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:STABStatera BioPharma Inc
27/02/202308:08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:STABStatera BioPharma Inc
15/02/202311:10Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:STABStatera BioPharma Inc
01/02/202318:35Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:STABStatera BioPharma Inc
01/02/202318:10Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)NASDAQ:STABStatera BioPharma Inc
14/11/202219:53Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:STABStatera BioPharma Inc
06/10/202207:01Edgar (US Regulatory)Annual Report (10-k)NASDAQ:STABStatera BioPharma Inc
23/09/202207:02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:STABStatera BioPharma Inc
26/08/202208:49GlobeNewswire Inc.Nasdaq Resumes Trading in Statera Biopharma, Inc.NASDAQ:STABStatera BioPharma Inc
25/08/202212:48GlobeNewswire Inc.Nasdaq Halts Statera Biopharma, Inc.NASDAQ:STABStatera BioPharma Inc
14/06/202208:30GlobeNewswire Inc.Statera Biopharma Announces BF Borgers CPA PC as Independent Registered Public Accounting FirmNASDAQ:STABStatera BioPharma Inc
23/05/202217:05GlobeNewswire Inc.Statera Biopharma Receives Notification Letter from Nasdaq Regarding Form 10-Q FilingNASDAQ:STABStatera BioPharma Inc
13/05/202208:30GlobeNewswire Inc.Statera Biopharma and Lay Sciences Inc. Announce Intent to Enter Strategic Partnership to License the Manufacturing Rights to Certain Lay Sciences IgY ProductsNASDAQ:STABStatera BioPharma Inc
27/04/202217:10GlobeNewswire Inc.Statera Biopharma and Immune Therapeutics Inc. Announce Strategic Agreement for Rights to Low Dose NaltrexoneNASDAQ:STABStatera BioPharma Inc
22/04/202218:26GlobeNewswire Inc.Statera Biopharma Receives Notification Letter from Nasdaq Regarding Form 10-K FilingNASDAQ:STABStatera BioPharma Inc
13/04/202217:05GlobeNewswire Inc.Statera Biopharma and Coeptis Therapeutics Announce Strategic Agreement for Rights to EntolimodNASDAQ:STABStatera BioPharma Inc
13/04/202208:00PR Newswire (US)Coeptis Therapeutics Announces Intent to Acquire TLR5 Agonist Platform, Including Clinical-Stage Asset Entolimod, from Statera BiopharmaNASDAQ:STABStatera BioPharma Inc
31/03/202217:05GlobeNewswire Inc.Statera Biopharma, Inc. Files Form 12b-25NASDAQ:STABStatera BioPharma Inc
28/03/202208:30GlobeNewswire Inc.Statera Biopharma, Inc. to Report Fourth Quarter and Full Year 2021 Financial Results on March 31, 2022NASDAQ:STABStatera BioPharma Inc
24/03/202218:28GlobeNewswire Inc.Statera Biopharma Announces Closing of $5.7 Million Underwritten Public OfferingNASDAQ:STABStatera BioPharma Inc
22/03/202210:29GlobeNewswire Inc.Statera Biopharma Announces Pricing of $5.7 Million Underwritten Public OfferingNASDAQ:STABStatera BioPharma Inc
22/03/202208:38GlobeNewswire Inc.CORRECTION -- Statera Biopharma Announces Proposed Underwritten Public OfferingNASDAQ:STABStatera BioPharma Inc
22/03/202208:34Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:STABStatera BioPharma Inc
21/03/202220:27Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:STABStatera BioPharma Inc
21/03/202217:50GlobeNewswire Inc.Statera Biopharma Announces Proposed Underwritten Public OfferingNASDAQ:STABStatera BioPharma Inc
08/03/202218:15GlobeNewswire Inc.Statera Biopharma Announces Revised Preliminary Revenue and Financial Results of Fiscal Year 2021NASDAQ:STABStatera BioPharma Inc
07/03/202209:30GlobeNewswire Inc.Statera Biopharma Advances Next-Gen Proprietary Compositions Based on STAT-200 PlatformNASDAQ:STABStatera BioPharma Inc
02/03/202211:08GlobeNewswire Inc.CORRECTION - Statera Biopharma Submits Phase 1 Clinical Trial Protocol to FDA for Investigational Treatment of Long-Haul COVID-19NASDAQ:STABStatera BioPharma Inc
02/03/202209:30GlobeNewswire Inc.Statera Biopharma Submits Phase 1 Clinical Trial Protocol to FDA for Investigational Treatment of Long-Haul COVID-19NASDAQ:STABStatera BioPharma Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:STAB

Seu Histórico Recente

TSXV
SLG
San Lorenzo Gold
FX
ZARZMW
ZAR vs ZMW
NASDAQ
XPDBU
Power and Digital Infras...
NYSE
NKX
Nuveen California AMT Fr...
LSE
PIRI
Pires Investments
LSE
IAE
Ithaca Energy
TSXV
KSK
Kiska Metals Corporation
TSXV
PBR
Para Resources
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados